Candriam S.C.A. Revolution Medicines, Inc. Transaction History

Candriam S.C.A.

$15.6 Billion
Q1 2025

A detailed history of Candriam S.C.A. transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Candriam S.C.A. holds 655,134 shares of RVMD stock, worth $26.3 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

655,134

Previous 656,740 0.24%

Holding current value

$26.3 Million

Previous $28.7 Million 19.36%

% of portfolio

0.15%

Previous 0.17%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$35.36 - $44.42 $56,788 - $71,338	-1,606 Reduced 0.24%	655,134 $23.2 Million
Q4 2024 Feb 06, 2025	BUY	$42.97 - $60.6 $3.99 Million - $5.63 Million	92,958 Added 16.49%	656,740 $28.7 Million
Q3 2024 Nov 13, 2024	BUY	$36.92 - $47.94 $348,820 - $452,937	9,448 Added 1.7%	563,782 $25.5 Million
Q2 2024 Aug 05, 2024	SELL	$30.14 - $40.68 $892,626 - $1.2 Million	-29,616 Reduced 5.07%	554,334 $21.5 Million
Q1 2024 May 03, 2024	SELL	$26.56 - $33.55 $610,880 - $771,649	-23,000 Reduced 3.79%	583,950 $18.8 Million
Q4 2023 Feb 14, 2024	BUY	$18.35 - $34.12 $825,786 - $1.54 Million	45,002 Added 8.01%	606,950 $17.4 Million
Q3 2023 Nov 13, 2023	SELL	$25.17 - $35.05 $453,060 - $630,900	-18,000 Reduced 3.1%	561,948 $15.6 Million
Q2 2023 Aug 08, 2023	SELL	$20.28 - $27.0 $535,067 - $712,368	-26,384 Reduced 4.35%	579,948 $15.5 Million
Q1 2023 May 12, 2023	SELL	$20.76 - $30.09 $2.62 Million - $3.8 Million	-126,173 Reduced 17.22%	606,332 $13.1 Million
Q3 2022 Nov 10, 2022	BUY	$17.46 - $26.0 $3.09 Million - $4.61 Million	177,250 Added 31.92%	732,505 $14.4 Million
Q2 2022 Aug 03, 2022	BUY	$14.54 - $27.17 $1.76 Million - $3.29 Million	121,051 Added 27.88%	555,255 $10.8 Million
Q1 2022 May 13, 2022	SELL	$17.31 - $26.4 $280,041 - $427,099	-16,178 Reduced 3.59%	434,204 $11.1 Million
Q4 2021 Feb 10, 2022	SELL	$24.35 - $33.7 $949,650 - $1.31 Million	-39,000 Reduced 7.97%	450,382 $11.3 Million
Q3 2021 Nov 09, 2021	BUY	$23.95 - $33.41 $2.28 Million - $3.18 Million	95,312 Added 24.19%	489,382 $13.5 Million
Q2 2021 Jul 20, 2021	BUY	$29.0 - $47.44 $11.4 Million - $18.7 Million	394,060 Added 3940600.0%	394,070 $12.5 Million
Q1 2021 Apr 29, 2021	BUY	$37.21 - $54.43 $372 - $544	10 New	10 $0

Others Institutions Holding RVMD

# of Institutions

303

Shares Held

189M

Call Options Held

186K

Put Options Held

672K

View Full List

About Revolution Medicines, Inc.

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.53B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

More about RVMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account